Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Withdrawal; Therapeutic Substance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05056753
What this trial is testing

Heterodyned Whole-Body Vibration in Treatment of Opioid Withdrawal-Induced Anxiety

Who this might be right for
Opioid-use Disorder
PhotoPharmics, Inc. 80
Testing effectiveness (Phase 2)Study completedNCT02210195
What this trial is testing

Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence

Who this might be right for
Cannabis DependenceAlcohol DependenceCannabis Use Disorder+1 more
The Scripps Research Institute 20
Not applicableEnded earlyNCT05924945
What this trial is testing

Impact of Bridge™ Device to Treat Opioid Withdrawal Symptoms

Who this might be right for
Opioid Use Disorder
Masimo Corporation 13
Post-approval studies (Phase 4)Study completedNCT01804075
What this trial is testing

Comparison Between Methadone and Morphine for Neonatal Opiate Withdrawal

Who this might be right for
Neonatal Abstinence Syndrome
Eastern Maine Medical Center 31
Post-approval studies (Phase 4)Study completedNCT01664741
What this trial is testing

Nicotine Dependence, Withdrawal and Replacement Therapy Assessed by PET Imaging

Who this might be right for
Nicotine Dependence
Johns Hopkins University 127
Large-scale testing (Phase 3)Study completedNCT03918850
What this trial is testing

Medication Treatment for Opioid Use Disorder in Expectant Mothers

Who this might be right for
Opioid-Related DisordersDrug AddictionPregnancy Related+5 more
T. John Winhusen, PhD 140
Large-scale testing (Phase 3)Not Yet RecruitingNCT07148206
What this trial is testing

Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial

Who this might be right for
Opioid Use Disorder
Montefiore Medical Center 40
Large-scale testing (Phase 3)Study completedNCT02810782
What this trial is testing

How to Treat Opiate Withdrawal in Neonates

Who this might be right for
Neonatal Abstinence Syndrome
University of Zurich 120
Large-scale testing (Phase 3)Not Yet RecruitingNCT07148843
What this trial is testing

Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving

Who this might be right for
Alcohol Use Disorder (AUD)Withdrawal From Addictive Substance; DetoxificationCraving
Johns Hopkins University 105
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07296094
What this trial is testing

Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder

Who this might be right for
Alcohol Use Disorder
Brigham and Women's Hospital 36
Not applicableUnknownNCT05512091
What this trial is testing

Characterization of the Pattern of Consumption and Withdrawal Syndrome From Dual Cannabis and Tobacco Use

Who this might be right for
Cannabis DependenceTobacco UseWithdrawal Syndrome+1 more
Cristina Martínez Martínez 282
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07810946
What this trial is testing

Intravenous Acetate as an Adjunctive Treatment for Alcohol Withdrawal in Hospitalized Patients

Who this might be right for
Alcohol WithdrawalAlcohol AbstinenceAlcohol Use Disorder
University of Colorado, Denver 75
Not applicableStudy completedNCT02952846
What this trial is testing

Tapering of Analgosedation and Occurrence of Withdrawal Syndrome in Paediatric Intensive Care Treatment

Who this might be right for
Drug Withdrawal SymptomsCritical CareChild
Oslo University Hospital 80
Large-scale testing (Phase 3)Study completedNCT01262261
What this trial is testing

Re-Treatment Study of Probuphine in Opioid Addiction

Who this might be right for
Opioid Dependency
Titan Pharmaceuticals 85
Large-scale testing (Phase 3)WithdrawnNCT03678792
What this trial is testing

Comparison of Three Opioid Detoxification Treatment Regimens

Who this might be right for
Opioid-Related DisordersOpioid Withdrawal
University of Alabama at Birmingham
Early research (Phase 1)Looking for participantsNCT06538558
What this trial is testing

Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder

Who this might be right for
Opioid Use Disorder
Proniras Corporation 40
Large-scale testing (Phase 3)Study completedNCT03365817
What this trial is testing

Cognitive Function and Addiction Under Opioid Tapering

Who this might be right for
Chronic PainOpioid Use
Rigshospitalet, Denmark 75
Not applicableLooking for participantsNCT06878287
What this trial is testing

Bright Light Therapy During Residential Alcohol Withdrawal

Who this might be right for
Alcohol Use DisorderAlcohol Withdrawal
Centre Hospitalier St Anne 100
Large-scale testing (Phase 3)Study completedNCT00630201
What this trial is testing

Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence

Who this might be right for
Opioid Dependence
Titan Pharmaceuticals 62
Testing effectiveness (Phase 2)Study completedNCT00395044
What this trial is testing

Gabapentin Treatment of Cannabis Dependence

Who this might be right for
Cannabis Dependence
The Scripps Research Institute 50
Next Page